OOIR: Observatory of International Research

Papers

(The TQCC of Expert Review of Neurotherapeutics is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Current perspectives on the recognition and diagnosis of low CSF pressure headache syndromes	40
The latest developments in synthetic approaches to Duchenne muscular dystrophy	40
Emerging antibody-based therapies for Huntington’s disease: current status and perspectives for future development	32
Immunomodulatory effects and clinical benefits of intravenous immunoglobulin in myasthenia gravis	31
Determining minimally clinically important differences for outcome measures in patients with chronic motor deficits secondary to traumatic brain injury	27
Assessment of clinical outcomes of medicinal cannabis therapy for depression: analysis from the UK Medical Cannabis Registry	27
The latest developments with internet-based psychological treatments for depression	26
A systematic review of European regional and national guidelines: a focus on the recommended use of nabiximols in the management of spasticity in multiple sclerosis	26
Current perspectives on the clinical management of cryptogenic stroke	26
An update on the treatment and management of cognitive dysfunction in patients with multiple sclerosis	25
Is it possible to prevent relapse in panic disorder?	22
Managing cognitive impairment in Parkinson’s disease: an update of the literature	22
Alpha-synuclein in Parkinson's disease: a villain or tragic hero? A critical view of the formation of α-synuclein aggregates induced by dopamine metabolites and viral infection	22
Where Art Thou O treatment for diabetic neuropathy: the sequel	21
Overcoming barriers to the management of seizure clusters: ease of use and time to administration of rescue medications	21
Neonatal seizures treatment based on conventional multichannel EEG monitoring: an overview of therapeutic options	20
Diagnostic and therapeutic approach to drug-resistant juvenile myoclonic epilepsy	20
The impact of COVID-19 on palliative care for people with Parkinson’s and response to future pandemics	20
Developments in the assessment of non-motor disease progression in amyotrophic lateral sclerosis	20
Diagnosis of Lennox-Gastaut syndrome and strategies for early recognition	19
Current and emerging targeted therapies for spinal muscular atrophy	19
Does electrical stimulation still have a place in the treatment armamentarium for Bell’s palsy?	19
The management of neurofibromatosis type 1 (NF1) in children and adolescents	19
Efficacy analysis of three brain stimulation techniques for Alzheimer’s disease: a meta-analysis of repeated transcranial magnetic stimulation, transcranial direct current stimulation, and deep brain	19
Evaluating fenfluramine hydrochloride as an oral solution for the treatment of seizures associated with Lennox-Gastaut syndrome	19

How have the recent updated epilepsy classifications impacted on diagnosis and treatment?	19
Advances in the management of bipolar disorder in children and adolescents: an update on the literature	19
Combinations of dextromethorphan for the treatment of mood disorders - a review of the evidence	18
Current nonstimulant medications for adults with attention-deficit/hyperactivity disorder	17
Therapeutic plasma exchange with albumin: a new approach to treat Alzheimer’s disease	17
Cognitive function in diabetic persons with peripheral neuropathy: a systematic review and meta-analysis	17
Understanding and managing autonomic dysfunction in persons with multiple sclerosis	17
An evaluation of onobotulinumtoxinA as a therapeutic option for pediatric neurogenic detrusor overactivity	17
An updated brief overview on post-traumatic headache and a systematic review of the non-pharmacological interventions for its management	17
Nanomaterials in neuromodulation: what is the potential?	17
Why lithium should be used in patients with bipolar disorder? A scoping review and an expert opinion paper	17
A study protocol for an ongoing multi-arm, randomized, double-blind, sham-controlled clinical trial with digital features, using portable transcranial electrical stimulation and internet-based behavio	16
Teriflunomide: an oral therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis	15
Speech and language therapy in primary progressive aphasia: a critical review of current practice	14
Therapeutic issues in Guillain–Barré syndrome	14
Profiling deutetrabenazine extended-release tablets for tardive dyskinesia and chorea associated with Huntington’s disease	14
Spinal cord stimulation for gait disturbances in Parkinson’s disease	14
Imaging protocols for non-traumatic spinal cord injury: current state of the art and future directions	14
Beyond chronic migraine: a systematic review and expert opinion on the off-label use of botulinum neurotoxin type-A in other primary headache disorders	13
Neurology’s vital role in preventing unnecessary and potentially harmful pediatric studies	13
Ultrasensitive techniques and protein misfolding amplification assays for biomarker-guided reconceptualization of Alzheimer’s and other neurodegenerative diseases	13
Clinical neuroimaging in intracerebral haemorrhage related to cerebral small vessel disease: contemporary practice and emerging concepts	13
The influence of anxiety and depression on headache in adolescent migraineurs: a case-control study	13
Status epilepticus in pregnancy: a literature review and a protocol proposal	13
An update on the pharmacotherapeutic options for complex regional pain syndrome	12
An overview of the differences in the pharmacological management of post-traumatic stress disorder between women and men	12
Bipolar disorder staging and the impact it has on its management: an update	12
An updated review on prediction and preventive treatment of post-stroke depression	12
Family accommodation: a diagnostic feature of obsessive-compulsive disorder?	12
Central vestibular dysfunction: don’t forget vestibular rehabilitation	12
Radiosurgical thalamotomy for essential tremor: state of the art, current challenges and future directions	11
Tele-healthcare in migraine medicine: from diagnosis to monitoring treatment outcomes	11
Overcoming clinical challenges of refractory neuropathic pain	11
Transcranial direct-current stimulation of the prefrontal cortex enhances working memory and suppresses pathological gamma power elevation in schizophrenia	11
Neuromodulation as a therapeutic approach for post-traumatic stress disorder: the evidence to date	11
Tailoring the therapeutic interventions for behavioral and psychological symptoms of dementia	11
The second phase of brain trauma can be controlled by nutraceuticals that suppress DAMP-mediated microglial activation	10
Emerging biomarkers to predict clinical outcomes in Guillain–Barré syndrome	10
Correction	10
Recent advances in understanding the neurobiology of pediatric functional neurological disorder	10
Clinical development of valbenazine for tics associated with Tourette syndrome	10
Tumefactive demyelination: updated perspectives on diagnosis and management	10
When is pharmacological intervention recommended for adults with social anxiety disorder?	10
The role of Fecal Microbiota Transplantation (FMT) in treating patients with multiple sclerosis	10
Developments in targeting calcitonin gene-related peptide	10
Pharmacological interventions to improve sleep in people with Alzheimer’s disease: a meta-analysis of randomized controlled trials	10
Behavioural Therapy for tic disorders: a comprehensive review of the literature	10
Outcomes measures in idiopathic intracranial hypertension	9
The current status of somatostatin analogs in the treatment of neuroendocrine tumors and future perspectives	9
Gantenerumab for early Alzheimer’s disease: a systematic review and meta-analysis	9

The relevance of cortical thickness in migraine sufferers and implications to therapy	9
Charcot-Marie-Tooth disease: a review of clinical developments and its management - What’s new in 2025?	9
Conventional and emerging treatments and controversies in myasthenia gravis	9
Advances in the treatment and management of frontotemporal dementia	9
Laser interstitial thermal therapy for recurrent brain metastases following stereotactic radiosurgery: a systematic review	9
Sublingual dexmedetomidine: repurposing an anesthetic as an anti-agitation agent	8
Advances in the treatment of human T-cell lymphotropic virus type-I associated myelopathy	8
Emerging role of artificial intelligence in stroke imaging	8
Emerging strategies and clinical recommendations for the management of novel depression subtypes	8
Challenges in the treatment of dysthymia: a narrative review	8
Long-term central nervous system (CNS) consequences of COVID-19 in children	8
Pharmacotherapy of schizophrenia: immunological aspects and potential role of immunotherapy	8
An update on the role of magnetic resonance imaging in predicting and monitoring multiple sclerosis progression	8
Pharmacological options for narcolepsy: are they the way forward?	8
A review of a diazepam nasal spray for the treatment of acute seizure clusters and prolonged seizures	8
The importance of synthetic pharmacotherapy for recessive cerebellar ataxias	8
Telerehabilitation in neurorehabilitation: has it passed the COVID test?	8
Personal narratives and the pursuit of purpose and possibility in psychosis: directions for developing recovery-oriented treatments	7
An update on combination therapies for multiple sclerosis: where are we now?	7
Role of environmental factors in multiple sclerosis	7
The donepezil transdermal system for the treatment of patients with mild, moderate, or severe Alzheimer’s disease: a critical review	7
Insights into headache 2022	7
Advances in the systemic therapy for recurrent meningiomas and the challenges ahead	7
Neuromodulation as a treatment strategy in Lennox-Gastaut syndrome: evidence and future directions	7
The early recognition and diagnosis of neoplastic meningitis	7
Omaveloxolone for the treatment of Friedreich ataxia: clinical trial results and practical considerations	7
Seizure medication and planned pregnancy: balancing the risks and outcomes	7
Considering safety and patient tolerance in the use of ketogenic diet in the management of refractory and super-refractory status epilepticus: a systematic review	7
Updated review on the link between cortical spreading depression and headache disorders	7
Impact of psychiatric comorbidities on the treatment of epilepsies in adults	7
Recent advancements in tension-type headache: a narrative review	7
Use of cenobamate for the treatment of focal epilepsy: an Italian expert opinion paper	7
Viltolarsen: a treatment option for Duchenne muscular dystrophy patients who are amenable to exon 53 skipping therapy	7
Suicidality and antiepileptic drugs in people with epilepsy: an update	7